Literature DB >> 21557096

Estimation of the lifetime risk of hip fracture for women and men in Canada.

R B Hopkins1, E Pullenayegum, R Goeree, J D Adachi, A Papaioannou, W D Leslie, J E Tarride, L Thabane.   

Abstract

UNLABELLED: In Canada in 2008, based on current rates of fracture and mortality, a woman or man at age 50 years will have a projected lifetime risk of fracture of 12.1% and 4.6%, respectively, and 8.9% and 6.7% after incorporating declining rates of hip fracture and increases in longevity.
INTRODUCTION: In 1989, the lifetime risk of hip fractures in Canada was 14.0% (women) and 5.2% (men). Since then, there have been changes in rates of hip fracture and increased longevity. We update these estimates to 2008 adjusted for these trends, and in addition, we estimated the lifetime risk of first hip fracture.
METHODS: We used national administrative data from fiscal year April 1, 2007 to March 31, 2008 to identify all hip fractures in Canada. We estimated the crude lifetime risk of hip fracture for age 50 years to end of life using life tables. We projected lifetime risk incorporating national trends in hip fracture and increased longevity from Poisson regressions. Finally, we removed the percentage of second hip fractures to estimate the lifetime risk of first hip fracture.
RESULTS: From April 1, 2007 to March 31, 2008, there were 21,687 hip fractures, 15,742 (72.6%) in women and 5,945 (27.4%) in men. For women and men, the crude lifetime risk was 12.1% (95%CI, 12.1, 12.2%) and 4.6% (95%CI, 4.5, 4.7%), respectively. When trends in mortality and hip fractures were both incorporated, the lifetime risk of hip fracture were 8.9% (95%CI, 2.3, 15.4%) and 6.7% (95%CI, 1.2, 12.2%). The lifetime risks for first hip fracture were 7.3% (95%CI, 0.8, 13.9%) and 6.2% (95%CI, 0.7, 11.7%).
CONCLUSIONS: The lifetime risk of hip fracture has fallen from 1989 to 2008 for women and men. Adjustments for trends in mortality and rates of hip fracture with removing second fractures produced non-significant differences in estimates.

Entities:  

Mesh:

Year:  2011        PMID: 21557096      PMCID: PMC5101063          DOI: 10.1007/s00198-011-1652-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  23 in total

1.  Modifiable and nonmodifiable factors associated with osteoporosis in postmenopausal women: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  A M Snelling; C J Crespo; M Schaeffer; S Smith; L Walbourn
Journal:  J Womens Health Gend Based Med       Date:  2001 Jan-Feb

2.  Placebo-controlled trials in osteoporosis--proceeding with caution.

Authors:  Clifford J Rosen; Sundeep Khosla
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

Review 3.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

4.  Using vital statistics to estimate the population-level impact of osteoporotic fractures on mortality based on death certificates, with an application to France (2000-2004).

Authors:  Nelly Ziadé; Eric Jougla; Joël Coste
Journal:  BMC Public Health       Date:  2009-09-17       Impact factor: 3.295

Review 5.  Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study.

Authors:  T Nymark; J M Lauritsen; O Ovesen; N D Röck; B Jeune
Journal:  Osteoporos Int       Date:  2006-07-06       Impact factor: 4.507

Review 6.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

7.  Second hip fracture in older men and women: the Framingham Study.

Authors:  Sarah D Berry; Elizabeth J Samelson; Marian T Hannan; Robert R McLean; Mei Lu; L Adrienne Cupples; Michele L Shaffer; Alexa L Beiser; Margaret Kelly-Hayes; Douglas P Kiel
Journal:  Arch Intern Med       Date:  2007-10-08

8.  International variations in hip fracture probabilities: implications for risk assessment.

Authors:  John A Kanis; Olof Johnell; Chris De Laet; Bengt Jonsson; Anders Oden; Alan K Ogelsby
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

9.  Cost effectiveness of screen-and-treat strategies for low bone mineral density: how do we screen, who do we screen and who do we treat?

Authors:  John T Schousboe
Journal:  Appl Health Econ Health Policy       Date:  2008       Impact factor: 2.561

10.  Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001.

Authors:  Jesper Ryg; Lars Rejnmark; Soren Overgaard; Kim Brixen; Peter Vestergaard
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

View more
  19 in total

Review 1.  Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.

Authors:  M A Wendl-Soeldner; C W I Moll; C Kammerlander; M Gosch; T Roth
Journal:  Z Gerontol Geriatr       Date:  2014-02       Impact factor: 1.281

2.  UNDERSTANDING OSTEOPOROSIS SCREENING PRACTICES IN MEN: A NATIONWIDE PHYSICIAN SURVEY.

Authors:  Palak Choksi; Brittany L Gay; David Reyes-Gastelum; Megan R Haymart; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2020-06-23       Impact factor: 3.443

Review 3.  Management of osteoporosis in older men.

Authors:  Jean-Marc Kaufman
Journal:  Aging Clin Exp Res       Date:  2021-04-05       Impact factor: 3.636

Review 4.  Osteoporosis in men: recent progress.

Authors:  Robert A Adler
Journal:  Endocrine       Date:  2013-01-25       Impact factor: 3.633

Review 5.  Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Authors:  Jacques P Brown; Suzanne Morin; William Leslie; Alexandra Papaioannou; Angela M Cheung; Kenneth S Davison; David Goltzman; David Arthur Hanley; Anthony Hodsman; Robert Josse; Algis Jovaisas; Angela Juby; Stephanie Kaiser; Andrew Karaplis; David Kendler; Aliya Khan; Daniel Ngui; Wojciech Olszynski; Louis-Georges Ste-Marie; Jonathan Adachi
Journal:  Can Fam Physician       Date:  2014-04       Impact factor: 3.275

6.  Diabetes and fractures: new evidence of atypical femoral fractures?

Authors:  N H Rasmussen; J Dal; F de Vries; J P van den Bergh; M H Jensen; P Vestergaard
Journal:  Osteoporos Int       Date:  2019-12-14       Impact factor: 4.507

7.  Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons.

Authors:  C Ruggiero; L Bonamassa; L Pelini; I Prioletta; L Cianferotti; A Metozzi; E Benvenuti; G Brandi; A Guazzini; G C Santoro; P Mecocci; D Black; M L Brandi
Journal:  Osteoporos Int       Date:  2016-10-07       Impact factor: 4.507

8.  Elderly males with or without existing osteoporotic vertebral fracture have much lower future vertebral fracture risk than elderly females: the MrOS (Hong Kong) year-4 follow-up spine radiograph study.

Authors:  Y X J Wáng; N Che-Nordin; M Deng; J F Griffith; J C S Leung; A W L Kwok; P C Leung; T C Y Kwok
Journal:  Osteoporos Int       Date:  2019-09-02       Impact factor: 4.507

9.  Deep Vein Thrombosis in Patients with Intertrochanteric Fracture: A Retrospective Study.

Authors:  Chen Fei; Peng-Fei Wang; Shuang-Wei Qu; Kun Shang; Kun Yang; Zhi Li; Yan Zhuang; Bin-Fei Zhang; Kun Zhang
Journal:  Indian J Orthop       Date:  2020-07-11       Impact factor: 1.251

10.  Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset.

Authors:  Giovanni Adami; Davide Gatti; Maurizio Rossini; Alessandro Giollo; Eugenia Bertoldo; Ombretta Viapiana; Pietro Olivi; Angelo Fassio
Journal:  Arch Osteoporos       Date:  2021-03-15       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.